HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrice Dubreuil Selected Research

Cutaneous Mastocytosis

1/2021Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-Up.
1/2013Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis.
12/2010Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrice Dubreuil Research Topics

Disease

22Neoplasms (Cancer)
01/2021 - 06/2002
16Mastocytosis
01/2022 - 07/2003
8Systemic Mastocytosis
11/2019 - 07/2003
3Cutaneous Mastocytosis
01/2021 - 12/2010
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2011
3Exanthema (Rash)
11/2017 - 04/2011
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2013 - 07/2003
2Inflammation (Inflammations)
01/2022 - 12/2016
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 11/2016
2Neuroinflammatory Diseases
01/2020 - 11/2016
2Mast Cell Activation Disorders (Mast-Cell Disease)
09/2019 - 01/2019
2Edema (Dropsy)
09/2019 - 06/2012
2Rheumatoid Arthritis
01/2019 - 01/2009
2Asthenia
11/2017 - 06/2012
2Paralysis (Palsy)
10/2017 - 11/2016
2Melanoma (Melanoma, Malignant)
06/2017 - 12/2015
2Mastocytoma
12/2016 - 02/2013
2Hematologic Neoplasms (Hematological Malignancy)
12/2016 - 08/2006
2Disease Progression
11/2016 - 05/2007
2Breast Neoplasms (Breast Cancer)
05/2007 - 05/2005
1Dyspnea (Shortness of Breath)
09/2019
1Asthma (Bronchial Asthma)
01/2019
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2016
1Thrombocytopenia (Thrombopenia)
06/2016
1Anemia
06/2016
1Deglutition Disorders (Dysphagia)
12/2015
1Brain Neoplasms (Brain Tumor)
12/2015
1Infarction (Infarctions)
01/2015
1Ischemic Stroke
01/2015
1Brain Ischemia (Cerebral Ischemia)
01/2015
1Neuroblastoma
01/2015
1Sarcoma (Soft Tissue Sarcoma)
01/2015
1Stroke (Strokes)
01/2015
1Hypersensitivity (Allergy)
07/2014
1Ascites
01/2014

Drug/Important Bio-Agent (IBA)

17masitinibIBA
01/2020 - 01/2009
12Phosphotransferases (Kinase)IBA
11/2019 - 02/2003
8Tyrosine Kinase InhibitorsIBA
01/2019 - 02/2003
5Biological ProductsIBA
01/2021 - 07/2010
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 08/2006
4Proteins (Proteins, Gene)FDA Link
08/2017 - 06/2002
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2015 - 07/2003
4Imatinib Mesylate (Gleevec)FDA Link
06/2013 - 02/2003
3NectinsIBA
05/2007 - 05/2004
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2017
2Pharmaceutical PreparationsIBA
01/2021 - 11/2016
2midostaurinIBA
11/2019 - 06/2016
2GemcitabineFDA Link
11/2017 - 03/2010
2AntigensIBA
12/2016 - 05/2007
2Tyrosine (L-Tyrosine)FDA Link
03/2010 - 06/2002
2Codon (Codons)IBA
03/2010 - 07/2003
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
09/2009 - 12/2005
2poliovirus receptorIBA
05/2004 - 07/2002
1ChromatinIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1VemurafenibIBA
01/2021
1purineIBA
01/2021
1RiluzoleFDA LinkGeneric
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Sorafenib (BAY 43-9006)FDA Link
11/2019
1crenolanibIBA
11/2019
1tyrosine receptor (receptor, tyrosine)IBA
11/2019
1gilteritinibIBA
11/2019
1quizartinibIBA
11/2019
1avapritinibIBA
11/2019
1Omalizumab (Xolair)FDA Link
09/2019
1Protein Kinase InhibitorsIBA
11/2017
1CytosineIBA
08/2017
15-hydroxymethylcytosineIBA
08/2017
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2017
1Cyclin-Dependent Kinase Inhibitor p16IBA
06/2017
1TensinsIBA
06/2017
1AllergensIBA
12/2016
1Growth Factor ReceptorsIBA
12/2016
1AntibodiesIBA
12/2016
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2016
1Cyclin DIBA
08/2016
1EnzymesIBA
06/2016
1CladribineFDA LinkGeneric
08/2015
1isocitric acid (isocitrate)IBA
01/2015
11,2-didecanoyl-3-phosphatidic acid (PA(10))IBA
01/2015
1RNA Splicing FactorsIBA
01/2015
1Arginine (L-Arginine)FDA Link
01/2015
1Oxidoreductases (Dehydrogenase)IBA
01/2015
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2015
1Serine (L-Serine)FDA Link
01/2015
1Neuroprotective AgentsIBA
01/2015
1Therapeutic UsesIBA
01/2015
1DioxygenasesIBA
01/2015
1Oncogene Proteins (Oncogene Protein)IBA
07/2014
1Immunoglobulin E (IgE)IBA
07/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2014
1Hemoglobins (Hemoglobin)IBA
01/2014

Therapy/Procedure

9Therapeutics
01/2021 - 03/2010
1Denervation
10/2017
1Precision Medicine
06/2017
1Oral Administration
11/2016
1Drug Therapy (Chemotherapy)
10/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2016